Investor Information

Press Releases

Resources

Legal Disclaimer

PRESS RELEASES

2014

July 23, 2014

PharmaRoth Labs, Inc. Announces New Distribution Agreement in China 

April 16, 2014

PharmaRoth Labs, Inc. Announces Mexican Distributor Surpasses Sales Goal 

March 24, 2014

PharmaRoth Labs, Inc. Announces Retail and Wholesale Distribution Channels in Mexico 

March 17, 2014

PharmaRoth Labs, Inc. Announces Results From FDA Application 

2013

September 26, 2013

PharmaRoth Labs Announces Publication of Diabetes Drug Clinical Trial Results 

August 19, 2013

PharmaRoth Labs Completes First Shipment with New Mexican Distributor 

June 05, 2013

PharmaRoth Labs Welcomes Two Respected Physicians to Board of Advisors 

May 28, 2013

PharmaRoth Labs Signs Definitive Distribution Agreement in Mexico 

May 01, 2013

PharmaRoth Labs, Inc. Announces Trading Symbol Change 

March 26, 2013

PharmaRoth Labs, Inc. Files New Dietary Ingredient Notification with the US Food and Drug Administration (FDA) 

March 25, 2013

Fero Industries, Inc. Changes Name to PharmaRoth Labs, Inc. 

January 22, 2013

Fero Industries, Inc. Announces Interim Chief Financial Officer 

2012

December 06, 2012

Fero Industries, Inc. Issues Corporate Update 

July 12, 2012

Fero Industries Announces Corporate Restructuring 

2011

December 22, 2011

Fero Industries Signs New Distribution Agreement to Expand Sucanon Distribution in the Middle East 

December 15, 2011

Fero Industries, Inc. Achieves First Certified Supplier Status to Distribute Sucanon® in Mexico 

October 05, 2011

Fero Industries Signs First Sucanon Distribution Agreement for the Middle East 

September 27, 2011

Fero Industries to Expand Sucanon® Distribution through Government Institutions in Mexico 

September 01, 2011

Fero Industries Appoints Lopez as President 

July 27, 2011

Fero Industries Increases Sucanon® Promotion in Mexico with Physician Distributed Sample Packages 

July 13, 2011

Fero Industries Expands Sucanon® Distribution in Mexico

June 23, 2011

Fero Industries Contracts PNP Pharmaceuticals for Exclusive Global Sucanon® Production

June 1, 2011

Fero Industries Successfully Completes Sucanon® Type-2 Diabetes Human Clinical Trials in the Middle East

May 19, 2011

Fero Industries Announces Third Quarter Results and Initial Revenue From Sucanon® Sales in Mexico

April 12, 2011

Fero Industries Appoints Lopez as Chief Operating Officer

March 31, 2011

Fero Industries Makes Third Commercial Shipment of Sucanon to Merck S.A.

March 16, 2011

Fero Industries Announces Commercial Launch of Sucanon in Mexico

February 16, 2011

Fero Industries Sucanon Middle East Clinical Trials Reach Final Phase

2010

December 20, 2010

Fero Industries Delivers First Shipment of Retail Packaged Sucanon to Merck S.A. de C.V.

December 15, 2010

Fero Industries Receives Certification for Import of Sucanon Pre-Mix to Mexico and Makes First Product Shipment

November 10, 2010

Fero Industries Selects Dr. Linda Allison to Head Strategic Advisory Committee

September 7, 2010

Fero Industries Appoints Lopez to Board of Directors

July 20, 2010

Fero Industries Comments on Recent FDA Advisory Panel Recommendation on Avandia

June 30 , 2010

Fero Industries Completes Acquisition of Sucanon Diabetes Treatment

June 9, 2010

Fero Industries Signs Definitive Agreement to Acquire Sucanon Diabetes Treatment

May 24, 2010

Fero Industries Inc. Retains Key Personnel

April 23, 2010

Fero Industries, Inc. Enters into Letter of Intent

 

Home  |  Company  |  Diabetes  |  Sucanon  |  Investor Relations  |  Contact  |  Legal Disclaimer  |  Privacy Policy